|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 12, 2018 ) The orthobiologics market into product, application, and end user. On the basis of product, market is categorized into allografts, synthetic orthobiologics, PRP, BMAC, DBM, BMP, and viscosupplementation products. In 2017, viscosupplementation products segment is expected to account for largest share of market.
Download Free Brochure of Orthobiologics Market spread across 159 Pages, Profiling 15 Companies and Supported with 60 Tables and 38 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1209993 .
Report covers orthobiologics market across four major geographies, namely, North America, Europe, Asia Pacific, & RoW. North America expected to command largest share of market in 2017 due to increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures.
Key Audience of This Market as Follows:
• Orthobiologics Product Manufacturing Companies
• Product Suppliers, Distributors, and Channel Partners
• Hospitals and Ambulatory Care Centers
• Orthopedic and Dental Clinics
• Research Laboratories and CROs
• Research and Academic Institutes
• National and International Regulatory Authorities
• Government and Non-government Organizations
• Market Research Firms
More Information on Orthobiologics Market with Top Trends, Forecast and Analysis at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1209993 .
The orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, spinal fusion segment is expected to grow at highest CAGR during forecast period owing to factors like rising number of spinal fusion procedures, increasing adoption of allografts.
Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
Click for 22% Discount on “Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=1209993 .
The orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.
Geographical forecast,
“Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment.” On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research &academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.
ReportsnReports
Mr. Hrishikesh
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
